Massachusetts Financial Services Co. MA Sells 17,985 Shares of Qiagen N.V. (NYSE:QGEN)

Massachusetts Financial Services Co. MA reduced its holdings in shares of Qiagen N.V. (NYSE:QGEN) by 0.1% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 25,301,347 shares of the company’s stock after selling 17,985 shares during the period. Massachusetts Financial Services Co. MA owned approximately 0.11% of Qiagen worth $1,015,849,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Wealth Enhancement Advisory Services LLC bought a new position in Qiagen in the 4th quarter valued at approximately $202,000. Wells Fargo & Company MN raised its position in Qiagen by 31.8% in the fourth quarter. Wells Fargo & Company MN now owns 66,779 shares of the company’s stock valued at $2,974,000 after purchasing an additional 16,106 shares during the last quarter. GAMMA Investing LLC raised its position in Qiagen by 93.9% in the first quarter. GAMMA Investing LLC now owns 2,943 shares of the company’s stock valued at $118,000 after purchasing an additional 1,425 shares during the last quarter. LPL Financial LLC raised its holdings in Qiagen by 2.6% in the 4th quarter. LPL Financial LLC now owns 17,240 shares of the company’s stock valued at $768,000 after buying an additional 432 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its position in Qiagen by 66.3% during the 4th quarter. Ameriprise Financial Inc. now owns 63,026 shares of the company’s stock worth $2,807,000 after purchasing an additional 25,134 shares during the last quarter. 70.00% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. Barclays assumed coverage on shares of Qiagen in a report on Tuesday, June 24th. They set an “overweight” rating and a $55.00 price target for the company. Wall Street Zen raised Qiagen from a “buy” rating to a “strong-buy” rating in a research report on Thursday, May 15th. Bank of America boosted their target price on shares of Qiagen from $50.00 to $53.00 and gave the stock a “buy” rating in a research report on Thursday, June 26th. Redburn Atlantic lowered Qiagen from a “buy” rating to a “neutral” rating in a report on Friday, April 4th. Finally, Robert W. Baird upped their price target on Qiagen from $42.00 to $43.00 and gave the stock a “neutral” rating in a report on Monday, April 21st. Seven research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $49.40.

Qiagen Stock Performance

QGEN stock opened at $48.13 on Monday. The firm has a market cap of $10.70 billion, a PE ratio of 120.67, a P/E/G ratio of 2.45 and a beta of 0.68. The company has a quick ratio of 2.83, a current ratio of 3.37 and a debt-to-equity ratio of 0.40. The business has a 50 day moving average of $45.37 and a 200-day moving average of $42.81. Qiagen N.V. has a 12-month low of $37.63 and a 12-month high of $49.30.

Qiagen (NYSE:QGEN) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.55 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.05. Qiagen had a net margin of 4.68% and a return on equity of 14.61%. The company had revenue of $483.46 million during the quarter, compared to analyst estimates of $465.66 million. During the same quarter in the prior year, the business earned $0.44 earnings per share. The firm’s revenue for the quarter was up 5.2% on a year-over-year basis. As a group, sell-side analysts expect that Qiagen N.V. will post 2.26 earnings per share for the current year.

Qiagen Announces Dividend

The company also recently declared a dividend, which was paid on Thursday, July 10th. Stockholders of record on Thursday, July 3rd were paid a dividend of $0.25 per share. The ex-dividend date of this dividend was Wednesday, July 2nd. This represents a dividend yield of 0.52%. Qiagen’s payout ratio is 62.50%.

Qiagen Company Profile

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.